March 10, 2022, 4 p.m. PST / 7 p.m. EST

Join Psychedelics Today CEO Joe Moore and members of the Vital teaching team in thought-provoking discussion on the delivery of safe, effective treatment with psychedelics and the DNA of well-trained, informed practitioners.

The interest in psychedelics as a therapeutic tool is growing rapidly, and the demand for safe, ethical and effective treatment and integration is growing exponentially – with no signs of slowing. With demand projected to skyrocket for this specialized adjunct therapy, filling the ‘practitioner pipeline’ will be one of the greatest challenges to delivering psychedelic therapy en masse.

What are the gaps in the psychedelic training field, how are the demands for skilled practitioners likely to grow as regulations change in Canada and around the world, and what will be required to prepare healers for this new mental health paradigm?

Tune in for this crucial discussion for insights on:
● The opportunities for practitioners, today and tomorrow
● The value of personal experience with psychedelics for practitioners
● Creating a safe container for clients
● Balancing clinical and Indigenous practices 
● The importance of inclusion in the psychedelic healthcare field

Speakers:

Joe Moore
CEO & Co-Founder, Psychedelics Today
Joe earned a B.A. at Plymouth State University in Philosophy and has been studying psychedelics since 2001. After working for 20 years in software, Joe is dedicated to working towards improved drug policy and greater inclusion of psychedelics in culture. In 2016, Joe co-founded Psychedelics Today, a world-leading psychedelic education and media platform. The popular Psychedelics Today podcast has been downloaded over 2.4-million times, and the Psychedelics Today Psychedelic Education Center has enrolled over 9,000 students in psychedelic training e-learning courses.

Devon Christie, MD
Medical Director, Numinus Wellness
Dr. Christie, a clinical instructor with the UBC Department of Medicine, is also a family physician with a focused practice in Multidisciplinary Pain Management. She is a Registered Therapeutic Counsellor emphasizing Relational Somatic Therapy for trauma resolution and she is also trained to deliver both MDMA-assisted psychotherapy for PTSD (MAPS USA) and ketamine-assisted psychotherapy, in a research setting. She is a recognized speaker and expert on the potential for incorporating psychedelic assisted therapies in an improved health care model for the future.

Manesh Girn
Chief Research Officer, EntheoTech Bioscience
Manesh is a Ph.D. candidate in Neuroscience at McGill University and has been lead or co-author on over a dozen scientific publications and book chapters on topics including psychedelics, meditation, mind-wandering, and the default-mode network. His Ph.D. dissertation focuses on the default-mode network and he is also conducting research on the brain mechanisms underlying LSD, psilocybin, and DMT in collaboration with Dr. Robin Carhart-Harris and others from the Imperial College London Center for Psychedelic Research. In his free time, he also runs a YouTube channel, The Psychedelic Scientist, where he discusses the latest findings in psychedelic science in an easy to understand, but non- superficial form.

Shannon Dames
Founder, Roots to Thrive
Shannon developed the Roots Theory and works as a nursing professor and resilience researcher. As a byproduct of her doctoral work that focused on the core factors that promote human flourishing, and as a Health Professional Investigator for the Michael Smith Foundation for Health Research, Dr. Dames is now spearheading the ongoing development of Roots to Thrive (RTT) and the integration of psychedelic-assisted therapies (RTT-KaT).

Pamela Kryskow, MD
Host
Dr. Kryskow is a medical doctor in Vancouver, British Columbia. Her training includes Family Medicine, Rural Emergency Medicine, Chronic pain, Functional Medicine and Ketamine Assisted Psychotherapy. She is currently working with colleagues on research related to Ketamine Assisted Psychotherapy, Psychedelic Microdosing, MDMA for Chronic Pain, Psilocybin, and Psychedelic therapy. Dr. Kryskow has signed the North Star Ethics Pledge.

Each registered attendee will receive a FREE copy of the Psychedelics Today Navigating Psychedelics: Trip Journal when they sign up for the Psychedelics Today newsletter! And as an added bonus, attendees will also receive access to two FREE Psychedelics Today online courses.

Register for your FREE ticket HERE. Follow the instructions on the ticketing page to sign up for the newsletter and redeem your welcome gifts.